Choy, Cecily http://orcid.org/0000-0003-4313-1548
Chen, Joseph
Li, Jiangyuan http://orcid.org/0000-0002-2147-5908
Gallagher, D. Travis
Lu, Jian
Wu, Daichao http://orcid.org/0000-0003-2086-0190
Zou, Ainslee http://orcid.org/0009-0001-1035-9688
Hemani, Humza http://orcid.org/0000-0003-1766-683X
Baptiste, Beverly A.
Wichmann, Emily
Yang, Qian
Ciffelo, Jeffrey
Yin, Rui http://orcid.org/0000-0001-5330-8306
McKelvy, Julia
Melvin, Denise
Wallace, Tonya
Dunn, Christopher http://orcid.org/0000-0001-7899-0110
Nguyen, Cuong
Chia, Chee W.
Fan, Jinshui
Ruffolo, Jeannie
Zukley, Linda
Shi, Guixin
Amano, Tomokazu
An, Yang
Meirelles, Osorio
Wu, Wells W.
Chou, Chao-Kai
Shen, Rong-Fong
Willis, Richard A. http://orcid.org/0000-0001-6890-1268
Ko, Minoru S. H. http://orcid.org/0000-0002-3530-3015
Liu, Yu-Tsueng
De, Supriyo http://orcid.org/0000-0002-2075-7655
Pierce, Brian G. http://orcid.org/0000-0003-4821-0368
Ferrucci, Luigi http://orcid.org/0000-0002-6273-1613
Egan, Josephine http://orcid.org/0000-0002-8945-0053
Mariuzza, Roy http://orcid.org/0000-0003-0748-5875
Weng, Nan-Ping http://orcid.org/0000-0001-8175-8953
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (AG000757)
Article History
Received: 4 April 2023
Accepted: 11 October 2023
First Online: 23 October 2023
Competing interests
: Y-T.L. is the founder of Diagnologix LLC and G.S. works for Diagnologix LLC. M.S.H.K. is the founder of Elixirgen Therapeutics, Inc and T.A. works for Elixirgen Therapeutics, Inc. The rest of authors declare no conflict of interests.